Literature DB >> 29891903

Modular cell-internalizing aptamer nanostructure enables targeted delivery of large functional RNAs in cancer cell lines.

David Porciani1,2,3, Leah N Cardwell4, Kwaku D Tawiah5,6, Khalid K Alam5,6,7, Margaret J Lange4,5, Mark A Daniels4, Donald H Burke8,9,10,11.   

Abstract

Large RNAs and ribonucleoprotein complexes have powerful therapeutic potential, but effective cell-targeted delivery tools are limited. Aptamers that internalize into target cells can deliver siRNAs (<15 kDa, 19-21 nt/strand). We demonstrate a modular nanostructure for cellular delivery of large, functional RNA payloads (50-80 kDa, 175-250 nt) by aptamers that recognize multiple human B cell cancer lines and transferrin receptor-expressing cells. Fluorogenic RNA reporter payloads enable accelerated testing of platform designs and rapid evaluation of assembly and internalization. Modularity is demonstrated by swapping in different targeting and payload aptamers. Both modules internalize into leukemic B cell lines and remained colocalized within endosomes. Fluorescence from internalized RNA persists for ≥2 h, suggesting a sizable window for aptamer payloads to exert influence upon targeted cells. This demonstration of aptamer-mediated, cell-internalizing delivery of large RNAs with retention of functional structure raises the possibility of manipulating endosomes and cells by delivering large aptamers and regulatory RNAs.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29891903      PMCID: PMC5995956          DOI: 10.1038/s41467-018-04691-x

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  70 in total

1.  RNA aptamer-based functional ligands of the neurotrophin receptor, TrkB.

Authors:  Yang Zhong Huang; Frank J Hernandez; Bin Gu; Katie R Stockdale; Kishore Nanapaneni; Todd E Scheetz; Mark A Behlke; Andrew S Peek; Thomas Bair; Paloma H Giangrande; James O McNamara
Journal:  Mol Pharmacol       Date:  2012-06-29       Impact factor: 4.436

2.  NUPACK: Analysis and design of nucleic acid systems.

Authors:  Joseph N Zadeh; Conrad D Steenberg; Justin S Bois; Brian R Wolfe; Marshall B Pierce; Asif R Khan; Robert M Dirks; Niles A Pierce
Journal:  J Comput Chem       Date:  2011-01-15       Impact factor: 3.376

3.  Universal aptamer-based real-time monitoring of enzymatic RNA synthesis.

Authors:  Katharina Höfer; Lisa V Langejürgen; Andres Jäschke
Journal:  J Am Chem Soc       Date:  2013-09-04       Impact factor: 15.419

4.  A direct role for Met endocytosis in tumorigenesis.

Authors:  Carine Joffre; Rachel Barrow; Ludovic Ménard; Véronique Calleja; Ian R Hart; Stéphanie Kermorgant
Journal:  Nat Cell Biol       Date:  2011-06-05       Impact factor: 28.824

5.  Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras.

Authors:  Lee Adam Wheeler; Radiana Trifonova; Vladimir Vrbanac; Emre Basar; Shannon McKernan; Zhan Xu; Edward Seung; Maud Deruaz; Tim Dudek; Jon Ivar Einarsson; Linda Yang; Todd M Allen; Andrew D Luster; Andrew M Tager; Derek M Dykxhoorn; Judy Lieberman
Journal:  J Clin Invest       Date:  2011-05-16       Impact factor: 14.808

6.  Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras.

Authors:  James O McNamara; Eran R Andrechek; Yong Wang; Kristi D Viles; Rachel E Rempel; Eli Gilboa; Bruce A Sullenger; Paloma H Giangrande
Journal:  Nat Biotechnol       Date:  2006-06-25       Impact factor: 54.908

7.  RNA-Based Fluorescent Biosensors for Live Cell Imaging of Second Messenger Cyclic di-AMP.

Authors:  Colleen A Kellenberger; Chen Chen; Aaron T Whiteley; Daniel A Portnoy; Ming C Hammond
Journal:  J Am Chem Soc       Date:  2015-05-15       Impact factor: 15.419

8.  Relative thermodynamic stability of DNA, RNA, and DNA:RNA hybrid duplexes: relationship with base composition and structure.

Authors:  E A Lesnik; S M Freier
Journal:  Biochemistry       Date:  1995-08-29       Impact factor: 3.162

9.  A New Transferrin Receptor Aptamer Inhibits New World Hemorrhagic Fever Mammarenavirus Entry.

Authors:  Keith E Maier; Rohit K Jangra; Kevin R Shieh; David K Cureton; Hui Xiao; Erik L Snapp; Sean P Whelan; Kartik Chandran; Matthew Levy
Journal:  Mol Ther Nucleic Acids       Date:  2016-05-24       Impact factor: 10.183

10.  Aptamer-Mediated Codelivery of Doxorubicin and NF-κB Decoy Enhances Chemosensitivity of Pancreatic Tumor Cells.

Authors:  David Porciani; Lorena Tedeschi; Laura Marchetti; Lorenzo Citti; Vincenzo Piazza; Fabio Beltram; Giovanni Signore
Journal:  Mol Ther Nucleic Acids       Date:  2015-04-28       Impact factor: 10.183

View more
  18 in total

1.  Activation of Innate Immune Responses by a CpG Oligonucleotide Sequence Composed Entirely of Threose Nucleic Acid.

Authors:  Margaret J Lange; Donald H Burke; John C Chaput
Journal:  Nucleic Acid Ther       Date:  2018-12-11       Impact factor: 5.486

Review 2.  Overcoming Major Barriers to Developing Successful Sensors for Practical Applications Using Functional Nucleic Acids.

Authors:  JingJing Zhang; Tian Lan; Yi Lu
Journal:  Annu Rev Anal Chem (Palo Alto Calif)       Date:  2022-02-25       Impact factor: 12.400

Review 3.  Uptake mechanisms of cell-internalizing nucleic acid aptamers for applications as pharmacological agents.

Authors:  Samira Husen Alamudi; Michiko Kimoto; Ichiro Hirao
Journal:  RSC Med Chem       Date:  2021-07-24

Review 4.  The dynamic, motile and deformative properties of RNA nanoparticles facilitate the third milestone of drug development.

Authors:  Xin Li; Abhjeet S Bhullar; Daniel W Binzel; Peixuan Guo
Journal:  Adv Drug Deliv Rev       Date:  2022-05-05       Impact factor: 17.873

5.  Aptamer-based photoelectrochemical assay for the determination of MCF-7.

Authors:  Junjun Luo; Dong Liang; Xiaoqing Li; Lei Deng; Zaoxia Wang; Minghui Yang
Journal:  Mikrochim Acta       Date:  2020-04-03       Impact factor: 5.833

Review 6.  Aptamers as Modular Components of Therapeutic Nucleic Acid Nanotechnology.

Authors:  Martin Panigaj; M Brittany Johnson; Weina Ke; Jessica McMillan; Ekaterina A Goncharova; Morgan Chandler; Kirill A Afonin
Journal:  ACS Nano       Date:  2019-11-05       Impact factor: 15.881

7.  Rationally designed DNA therapeutics can modulate human TH expression by controlling specific GQ formation in its promoter.

Authors:  Nathan Beals; Mohamed M Farhath; Prakash Kharel; Brintha Croos; Thulasi Mahendran; John Johnson; Soumitra Basu
Journal:  Mol Ther       Date:  2021-05-14       Impact factor: 11.454

Review 8.  Advances in intracellular delivery through supramolecular self-assembly of oligonucleotides and peptides.

Authors:  Jeonghwan Kim; Ashwanikumar Narayana; Siddharth Patel; Gaurav Sahay
Journal:  Theranostics       Date:  2019-05-18       Impact factor: 11.556

Review 9.  Aptamer Chimeras for Therapeutic Delivery: The Challenging Perspectives.

Authors:  Carla Lucia Esposito; Silvia Catuogno; Gerolama Condorelli; Paola Ungaro; Vittorio de Franciscis
Journal:  Genes (Basel)       Date:  2018-10-31       Impact factor: 4.096

Review 10.  Aptamer-iRNAs as Therapeutics for Cancer Treatment.

Authors:  Mario M Soldevilla; Daniel Meraviglia-Crivelli de Caso; Ashwathi P Menon; Fernando Pastor
Journal:  Pharmaceuticals (Basel)       Date:  2018-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.